Characterization of bla NDM in two Escherichia coli ST1193 clinical isolates in the Gulf region. [PDF]
JAC Antimicrob ResistIntroduction Escherichia coli ST1193 is an emerging high-risk clone associated with the production of plasmid-mediated CTX-type extended-spectrum β-lactamases. However, this clone has seldom been found to contain plasmids carrying carbapenemase genes. We
Tsui CK +6 more
europepmc +8 more sources
Fluoroquinolone resistance in complicated urinary tract infections: association with the increased occurrence and diversity of Escherichia coli of clonal complex 131, together with ST1193 [PDF]
Frontiers in Cellular and Infection MicrobiologyIntroductionUrinary tract infections (UTIs) are one of the leading causes of multidrug-resistance (MDR) spread and infection-related deaths. Escherichia coli is by far the main causative agent.
Isidro García-Meniño +13 more
doaj +6 more sources
Prevalence of Escherichia coli ST1193 Causing Intracranial Infection in Changsha, China
Tropical Medicine and Infectious Disease, 2022 ST1193 is an emerging new virulent and resistant clone among Escherichia coli with a tendency to spread rapidly across the globe. However, the prevalence of intracranial infection-causing E. coli ST1193 is rarely reported. This study aimed at determining
Yi-Ming Zhong +3 more
doaj +4 more sources
Escherichia coli ST1193: Following in the Footsteps of E. coli ST131
Antimicrobial Agents and Chemotherapy, 2022 Escherichia coli ST1193 is an emerging global multidrug (MDR) high-risk clone and an important cause of community-onset urinary and bloodstream infections.
Johann D D Pitout +2 more
exaly +4 more sources
Microbial Genomics, 2021 Extra-intestinal pathogenic Escherichia coli (ExPEC) ST1193, a globally emergent fluoroquinolone-resistant clone, has become an important cause of bloodstream infections (BSIs) associated with significant morbidity and mortality.
Quynh Nguyen, Vinh Châu, Stephen Baker
exaly +5 more sources
Infection and Drug Resistance, 2020 Jiangqing Huang,1 Shengcen Zhang,1 Shuyu Zhang,2 Zhichang Zhao,3 Yingping Cao,1 Min Chen,2 Bin Li1 1Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, People’s Republic of China; 2Department of ...
Huang J +6 more
doaj +5 more sources
Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and High-Risk Escherichia coli CC131, with the First Report of ST1193 as a Causative Agent of Urinary Tract Infections in Human Patients in Algeria [PDF]
AntibioticsBackground: High-risk Escherichia coli clones, such as sequence type (ST)131 and ST1193, along with multidrug-resistant (MDR) Klebsiella pneumoniae, are globally recognized for their significant role in urinary tract infections (UTIs).
Hajer Ziadi +5 more
doaj +3 more sources
Early-Onset Infection Caused by Escherichia coli Sequence Type 1193 in Late Preterm and Full-Term Neonates [PDF]
Emerging Infectious DiseasesUsing whole-genome sequencing, we characterized Escherichia coli strains causing early-onset sepsis (EOS) in 32 neonatal cases from a 2019–2021 prospective multicenter study in France and compared them to E.
Célie Malaure +9 more
doaj +3 more sources
Commensal Fitness Advantage May Contribute to the Global Dissemination of Multidrug-Resistant Lineages of Bacteria—The Case of Uropathogenic E. coli [PDF]
Pathogens, 2023 It is widely accepted that favorable fitness in commensal colonization is one of the prime facilitators of clonal dissemination in bacteria. The question arises as to what kind of fitness advantage may be wielded by uropathogenic strains of the two ...
Miklos Fuzi, Evgeni Sokurenko
doaj +3 more sources
The complete genome sequence of five pre-2013 Escherichia coli sequence type (ST)1193 strains reveals insights into an emerging pathogen. [PDF]
Access MicrobiolFluoroquinolone-resistant Escherichia coli sequence type (ST)1193 is a profound, emerging lineage associated with systemic, urinary tract and neonatal infections.
Rhys Thomas White +17 more
europepmc +5 more sources